NeoStem is engaged in the emerging cellular therapy industry, leveraging a business model that includes the development of novel proprietary cell therapy products as well as operating a contract development and manufacturing organization (“CDMO”) providing services to clients advancing regenerative medicine product candidates in the regenerative medicine industry; adult stem cell collection and storage services; and therapy development utilizing T-cells for autoimmune and inflammatory conditions. For more information visit the company’s Web site at www.neostem.com
Let us hear your thoughts below: